Stay updated on Ivermectin in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Ivermectin in Severe COVID-19 Clinical Trial page.

Latest updates to the Ivermectin in Severe COVID-19 Clinical Trial page
- Check7 days agoChange DetectedThe clinical trial results page now displays the study record for ivermectin treatment of severe COVID-19, including trial outcomes, safety results, investigator information, and related publications.SummaryDifference100%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check28 days agoChange DetectedA banner announces an NIH transition and says both “Super Intelligence” and “Artificial Intelligence” may appear across NIH content during the transition.SummaryDifference1%

- Check35 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedA 403 Forbidden page is now displayed, replacing the study results content; the page header shows a 403 message and a Home link while the detailed study information is no longer accessible.SummaryDifference22%

Stay in the know with updates to Ivermectin in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivermectin in Severe COVID-19 Clinical Trial page.